AN2 Therapeutics

📍 Menlo Park, United States🗓 Founded 2019👥 34 employees💰 Last funded May 2017
Biotechnology Research🌐 an2therapeutics.com
Website LinkedIn
AN2 Therapeutics, Inc. is a biopharmaceutical company dedicated to developing therapies to treat rare, chronic, and serious infectious diseases in areas of high unmet needs. Founded by a team of experienced industry leaders in infectious disease drug research and development and boron chemistry, we have a passion for addressing the challenges of infectious disease and improving global human health. For more information, please visit www.an2therapeutics.com.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in AN2 Therapeutics?
AN2 Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did AN2 Therapeutics last raise funding?
The most recent investment in AN2 Therapeutics recorded on gritt.io was in May 2017.
When was AN2 Therapeutics founded?
AN2 Therapeutics was founded in 2019.
What industry is AN2 Therapeutics in?
AN2 Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is AN2 Therapeutics based?
AN2 Therapeutics is headquartered in Menlo Park, United States.